Insulet Corporation

At Insulet, data is at the heart of our goal to revolutionize diabetes management and enhance the lives of those affected by this chronic condition. By partnering with global leaders like Salesforce, we continuously drive product innovation and deliver world-class user experiences. This collaboration empowers us to transform insights into action, providing more personalized and impactful solutions. To learn more, check out the press release from Salesforce that features our acting Chief Technology Officer, Amit Guliani: https://lnkd.in/eGz8Xzcc

Join us in welcoming Alice Bobovich to Team Insulet! Before stepping into her new role with our company, Alice worked as a software test engineer at another diabetes company. She holds a Master’s in Biomedical Engineering from the University of Southern California where she also completed her undergraduate studies in Biomedical Engineering with a Computer Programming minor. Welcome to the team Alice!

Join us in congratulating Lindsay Philbrick who is celebrating her 10th work anniversary! As Vice President of Product Marketing, Lindsay has played a key role in the launch and go to market strategy of the Omnipod® 5 System and delivering innovation to simplify life for people living with diabetes. Thank you, Lindsay, for your vision and leadership! #TeamInsulet

We are thrilled to announce the launch of the Omnipod 5® Automated Insulin Delivery (AID) System in Switzerland this week! This milestone marks another significant step in our mission to improve the lives of people with diabetes. So far this year, we have successfully introduced our flagship product to eight new countries, expanding our reach and impact globally, demonstrating our commitment to simplifying life with diabetes around the world.   Learn more: https://lnkd.in/e2BnzG3C #TeamInsulet

Creating opportunities for those interested in pursuing a career in robotics and manufacturing automation at our Acton, MA manufacturing facility — that’s the goal of Pathmaker, an 8-week workplace development program created through a joint partnership with Insulet, Mass Life Sciences, Mount Wachusett Community College, and Middlesex Community College.  Participants are trained to work in a variety of manufacturing roles at Insulet. Our Sr. Director of U.S. Operations, Peter Gowac Jr., was recently invited to share takeaways from the program’s success with other employers at the NEWN Conference.  Thanks to Pete and the rest of our operations team for their work on this impactful program! #TeamInsulet

As GVP, E2E Customer Experience Lead at Insulet, Curtis Kopf is accustomed to taking on big challenges. But his latest adventure took him to new heights! Curtis and his wife, Abbe Jacobson, recently embarked on one of their boldest journeys yet: climbing Mount Kilimanjaro in Tanzania, East Africa—the world’s highest freestanding mountain at 19,341 feet. Reflecting on their climb Curtis shared, “Find your wild place. Venture into spaces that will uncover unknown strength and resilience. And, in doing so, don’t be afraid to find your limits, too. I promise that you will be wiser, happier, and feel more alive.” #TeamInsulet

Diabetes Technology & Therapeutics recently published a Call to Action from a global coalition of clinicians, calling for Automated Insulin Delivery (AID) as a standard of care for people with type 1 diabetes.  The authors emphasized that while Continuous Glucose Monitoring (CGM) has significantly advanced diabetes care, it alone is not enough for many to achieve optimal glucose control. The study calls for broader implementation of AID systems, which combine CGM with insulin delivery, to improve outcomes and quality of life for people with type 1 diabetes. Key takeaways: - People with type 1 diabetes must be offered an AID system at the time of diagnosis or as soon after diagnosis as possible - Reasons for not offering AID to a patient should be documented in the medical record - Choice matters, and the choice of device should be based on the individual’s circumstances, needs and preferences - National health care systems should prioritize providing unrestricted access to AID systems to ensure everyone can benefit from their advantages.  Read the full article here: https://lnkd.in/eQcNaCq9

Join us in celebrating Emmalee Barton’s 5-year work anniversary at Insulet! As a Territory Sales Manager serving our customers in the Peoria, IL region, Emma has been an invaluable member of our team. We are incredibly grateful for the care and support she provides to our Podders and providers. Help us congratulate Emmalee on this milestone! #TeamInsulet

Insulet is excited to announce that Omnipod 5 ® Automated Insulin Delivery (AID) System is now available in Canada with public reimbursement coverage available initially in the provinces of Ontario and Nova Scotia. We are working diligently to secure broader public coverage across Canada.  Diabetes Canada guidelines now recommend using AID systems as the preferred treatment for people with type 1 diabetes in Canada. Check it out here: https://lnkd.in/e8SDCNKY #TeamInsulet

As we recognize Insulet's 25th anniversary, we've got even more reason to celebrate - 100K followers on LinkedIn!   Thank you to everyone following our Company’s journey to improve the lives of people with diabetes! #TeamInsulet